Blood biomarkers and treatment response in major depression
Open accessThe DOI matches its Crossref record; 148 of the 148 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Millions of people worldwide suffer from depression, but despite advances in pharmacological therapies, many patients do not experience symptomatic remission or treatment response, even after treatments with several medications. As such, there is an urgent need to identify biomarkers that can not only predict the treatment response but also allow a rational selection of optimal therapy for each patient. Areas covered: This review examines the recent findings, coming from different 'omic sciences,' in human blood-based biomarkers associated with antidepressant treatment response with particular attention on genetic/epigenetic and biochemical biomarkers. Specific emphasis will be placed on key molecules related to neuroplasticity and inflammation because of their involvement in the pathophysiology of depression and antidepressant response. Expert commentary: Biomarker identification is still an ongoing work. Indeed, to date, no biomarkers have sufficiently proven specificity, sensitivity, and reproducibility to be used in the clinical setting. However, 'omic' approaches hold great promise in identifying multiple features for predicting antidepressant response, making a personalized treatment strategy possible for each patient, and thereby assist with quick and efficacious responsiveness. It is thus necessary that future studies take an integrative approach that includes clinical assessment, environment influences, and molecular and biological biomarkers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679 · cited 2×
“The most common chemical modification is acetylation, which is catalyzed by histone acetyltranferase; other modifications include methylation, phosphorylation, ubiquitination, SUMOylation, citrullination, and ADP-ribosylation [70].”
Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
(2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.113989 · Cited by 6,762
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766 · cited 1×
“antidepressant drugs by several studies [117,118], suggesting that peripheral blood concentration of CRP might be useful to predict the future therapeutic response.”
BackgroundNeurotrophin regulation of neural circuit development and function
Park, H., & Poo, M.-M. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3379 · Cited by 2,060
An operational definition of epigenetics: Figure 1.
Berger, S. L., Kouzarides, T., Shiekhattar, R., & Shilatifard, A. (2009) · Genes & Development · doi:10.1101/gad.1787609 · Cited by 1,884 · cited 1×
“methylation, posttranslational modification of histones and microRNAs (miRNAs) [51].”
BackgroundRaison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617
Peripheral cytokine and chemokine alterations in depression: a meta‐analysis of 82 studies
Köhler, C. A., Freitas, T. H., Maes, M., de Andrade, N. Q., Liu, C. S., Fernandes, B. S., Stubbs, B., Solmi, M., Veronese, N., Herrmann, N., et al. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12698 · Cited by 1,443 · cited 1×
“depressed patients as compared to controls [103,104] and that changes in cytokines levels during antidepressant treatment correlate with treatment response [105–108].”
Result
Research works printed but not linked: 8
- Gadad BS, 2017, J Affect Disord
- Belzeaux R, 2017, J Affect Disord
- Winner JG, 2013, Discov Med, 16, 219
- Lopez JP, Mol Psychiatry (England, 2013), 398
- Harley J, J Psychopharmacol., 625
- 10.1016/j.biopsych.2014.06.021 · DOI · Paper page
- Hempstead BL, 2015, Trans Am Clin Climatol Assoc, 126, 9
- Shen X, 2014, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 31, 196
Cited by
Roughan, W. H., Campos, A. I., García‐Marín, L. M., Cuéllar-Partida, G., Lupton, M. K., Hickie, I. B., Medland, S. E., Wray, N. R., Byrne, E. M., Ngô, T. T., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.643609 · Cited by 190
“For all other substances, the response options were: “never” (0), “once or twice” (1), “monthly” (2), “weekly” (3), or “daily” (4).”
BackgroundThe HPA Axis as Target for Depression
Menke, A. (2024) · Current Neuropharmacology · doi:10.2174/1570159x21666230811141557 · Cited by 131
“Ad-ditionally, there are no genetic markers or biomarkers that reliably match patients with effective treatment options [14-16].”
BackgroundChanges in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca
Galvão-Coelho, N. L., de Menezes Galvão, A. C., de Almeida, R. N., Palhano-Fontes, F., Campos Braga, I., Lobão Soares, B., Maia-de-Oliveira, J. P., Perkins, D., Sarris, J., & de Araujo, D. B. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120936486 · Cited by 128
Sex differences in the blood–brain barrier: Implications for mental health
Dion‐Albert, L., Binder, L. B., Daigle, B., Hong-Minh, A., Lebel, M., & Ménard, C. (2022) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2022.100989 · Cited by 107
Gialluisi, A., Bonaccio, M., Castelnuovo, A. F. D., Costanzo, S., Curtis, A. D., Sarchiapone, M., Cerletti, C., Donati, M. B., de Gaetano, G., Iacoviello, L., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.04.041 · Cited by 104
Metadata
- Authors
- Mora, C., Zonca, V., Riva, M. A., & Cattaneo, A.
- Affiliations
- Centro San Giovanni di Dio Fatebenefratelli (IT)
- University of Milan (IT)
- King's College London (GB)
- Corresponding author
- Riva, Marco A.
- Venue
- Expert Review of Molecular Diagnostics
- Publisher
- Informa UK Limited
- Published
- 2018-06-03
- Volume
- 18
- Issue
- 6
- Pages
- 513-529
- ISSN
- 1473-7159 (ISSN-L)
- 1744-8352
- OpenAlex
- W2800578988
- Cited by
- 107
- References
- 148
- Citations by year
- 2026: 5 · 2025: 15 · 2024: 10 · 2023: 12 · 2022: 29 · 2021: 19 · 2020: 10 · 2019: 6
- FWCI
- 1.02
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- Expert Review of Molecular Diagnostics (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Ministry of Health
- Ministry of University and Research (PRIN grant number 2015SKN9YT)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- major depressive disorder, blood biomarkers, antidepressant response, treatment-resistant depression, genetic biomarkers, epigenetic biomarkers, neuroplasticity, inflammation, personalized medicine, omics approaches
- MeSH terms
- Major Depressive Disorder, Depressive Disorder, Major, Humans, Biomarkers, Genomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Blood biomarkers and treatment response in major depression. https://app.cochat.ai/papers/10.1080/14737159.2018.1470927
- The paper
- Mora, C., Zonca, V., Riva, M. A., & Cattaneo, A. (2018). Blood biomarkers and treatment response in major depression. Expert Review of Molecular Diagnostics. https://doi.org/10.1080/14737159.2018.1470927
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.